| RS1602630650 |
CACNA1F
|
Health Risk |
Pathogenic |
Congenital stationary night blindness, Congenital stationary night blindness 2A |
| RS1602632270 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1602635261 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1602635282 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1602635656 |
PCDH19
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1602635781 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1602636059 |
PCDH19
|
Health Risk |
Pathogenic |
— |
| RS1602636096 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1602636466 |
PCDH19
|
Health Risk |
Pathogenic |
— |
| RS1602636591 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1602636688 |
PCDH19
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 9 |
| RS1602636925 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1602636952 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1602637340 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1602637452 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1602637517 |
PCDH19
|
Health Risk |
Pathogenic |
— |
| RS1602637608 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1602637696 |
PCDH19
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1602637774 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1602638228 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1602638456 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1602638463 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1602638594 |
PCDH19
|
Health Risk |
Pathogenic |
— |
| RS1602639528 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS1602639607 |
CACNA1F
|
Health Risk |
Pathogenic |
Congenital stationary night blindness, Congenital stationary night blindness |
| RS1602641426 |
CACNA1F
|
Health Risk |
Pathogenic |
Congenital stationary night blindness, Congenital stationary night blindness |
| RS1602641906 |
POU3F4
|
Health Risk |
Likely pathogenic |
Ear malformation, Ear malformation |
| RS1602644716 |
CACNA1F
|
Health Risk |
Pathogenic |
Congenital stationary night blindness, Congenital stationary night blindness |
| RS1602647939 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS1602651770 |
COL18A1;SLC19A1
|
Health Risk |
Pathogenic |
Knobloch syndrome, Knobloch syndrome |
| RS1602653110 |
CACNA1F
|
Health Risk |
Pathogenic |
Cone-rod dystrophy, Nonpapillary renal cell carcinoma |
| RS1602653742 |
CACNA1F
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1602658505 |
CACNA1F
|
Health Risk |
Pathogenic |
Congenital stationary night blindness, Congenital stationary night blindness |
| RS1602667345 |
COL18A1
|
Health Risk |
Likely pathogenic |
Knobloch syndrome, Knobloch syndrome |
| RS1602669026 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602670769 |
EFNB1
|
Health Risk |
Pathogenic |
— |
| RS1602671282 |
EFNB1
|
Health Risk |
Likely pathogenic |
Craniofrontonasal syndrome, Craniofrontonasal syndrome |
| RS1602679037 |
FOXP3
|
Health Risk |
Pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS1602679681 |
FOXP3
|
Health Risk |
Likely pathogenic |
— |
| RS1602682433 |
FOXP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS1602683532 |
AP1B1
|
Health Risk |
Pathogenic |
Autosomal recessive keratitis-ichthyosis-deafness syndrome, Autosomal recessive keratitis-ichthyosis-deafness syndrome |
| RS1602684221 |
FOXP3
|
Health Risk |
Likely pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS1602684496 |
FOXP3
|
Health Risk |
Pathogenic |
Non-obstructive azoospermia, Non-obstructive azoospermia |
| RS1602693008 |
FOXP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS1602695527 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602695597 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602696519 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602708047 |
TRAPPC2
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia tarda, Spondyloepiphyseal dysplasia tarda |
| RS1602717625 |
TRAPPC2
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia tarda, Spondyloepiphyseal dysplasia tarda |
| RS1602717698 |
TRAPPC2
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia tarda, Spondyloepiphyseal dysplasia tarda |
| RS1602717803 |
PHF6
|
Health Risk |
Pathogenic |
— |
| RS1602725543 |
IDS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS1602725808 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS1602727611 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602728959 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602730254 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Thyroid cancer |
| RS1602730439 |
IDS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS1602734459 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS1602738933 |
HUWE1
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked syndromic |
| RS1602740899 |
IDS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-II |
| RS1602740912 |
IDS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS1602741150 |
HPRT1
|
Health Risk |
Pathogenic |
Lesch-Nyhan syndrome, Lesch-Nyhan syndrome |
| RS1602742620 |
IDS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS1602742808 |
ZIC3
|
Health Risk |
Pathogenic |
Heterotaxy, visceral |
| RS1602742854 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS1602743059 |
ZIC3
|
Health Risk |
Likely pathogenic |
Heterotaxy, visceral |
| RS1602745376 |
HPRT1
|
Health Risk |
Pathogenic |
Lesch-Nyhan syndrome, Partial hypoxanthine-guanine phosphoribosyltransferase deficiency |
| RS1602745838 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS1602748255 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS1602749181 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS1602749299 |
AP1B1
|
Health Risk |
Pathogenic |
Autosomal recessive keratitis-ichthyosis-deafness syndrome, Autosomal recessive keratitis-ichthyosis-deafness syndrome |
| RS1602750400 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS1602750610 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS1602761438 |
AP1B1
|
Health Risk |
Pathogenic |
Autosomal recessive keratitis-ichthyosis-deafness syndrome, Autosomal recessive keratitis-ichthyosis-deafness syndrome |
| RS1602765633 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602765856 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602766499 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602766531 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602766655 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602766725 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS160278 |
VCAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Vitreoretinopathy, Vitreoretinopathy |
| RS1602780580 |
OCRL
|
Health Risk |
Pathogenic |
— |
| RS1602782082 |
OCRL
|
Health Risk |
Likely pathogenic |
Dent disease type 2, Dent disease type 2 |
| RS1602782195 |
OCRL
|
Health Risk |
Pathogenic |
Lowe syndrome, Lowe syndrome |
| RS1602783564 |
OCRL
|
Health Risk |
Likely pathogenic |
Lowe syndrome, Lowe syndrome |
| RS1602791255 |
OCRL
|
Health Risk |
Pathogenic |
Lowe syndrome, Lowe syndrome |
| RS1602791884 |
FRMD7
|
Health Risk |
Pathogenic |
Nystagmus 1, congenital |
| RS1602799769 |
KDM6A
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS1602802472 |
OCRL
|
Health Risk |
Pathogenic |
Lowe syndrome, Lowe syndrome |
| RS1602802640 |
OCRL
|
Health Risk |
Likely pathogenic |
Lowe syndrome, Lowe syndrome |
| RS1602818783 |
OCRL
|
Health Risk |
Pathogenic |
— |
| RS1602819835 |
OCRL
|
Health Risk |
Pathogenic |
Lowe syndrome, Dent disease type 2 |
| RS1602820970 |
OCRL
|
Health Risk |
Likely pathogenic |
Lowe syndrome, Lowe syndrome |
| RS1602822117 |
KDM6A
|
Health Risk |
Pathogenic |
— |
| RS1602826217 |
OFD1
|
Health Risk |
Likely pathogenic |
Orofaciodigital syndrome I, Orofaciodigital syndrome I |
| RS1602857000 |
DLG3
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, X-linked 90 |
| RS1602868720 |
KDM6A
|
Health Risk |
Pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS1602876401 |
ATRX
|
Health Risk |
Likely pathogenic |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS1602878106 |
MSN
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to moesin deficiency, Combined immunodeficiency due to moesin deficiency |
| RS1602880906 |
DLG3
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |